Standout Papers

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refracto... 1998 2026 2007 2016 3.8k
  1. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer (2004)
    David Cunningham, Yves Humblet et al. New England Journal of Medicine
  2. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer (1998)
    Philippe Rougier, Eric Van Cutsem et al. The Lancet

Immediate Impact

4 by Nobel laureates 5 from Science/Nature 194 standout
Sub-graph 1 of 14

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
2 intermediate papers

Works of Harry Bleiberg being referenced

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout

Author Peers

Author Last Decade Papers Cites
Harry Bleiberg 7126 4086 2433 160 10.0k
Joan Maurel 6768 3349 2054 214 8.6k
Alberto Sobrero 9402 3787 1936 199 11.8k
C. Boni 10741 5397 3241 118 13.6k
Gunnar Folprecht 8392 3539 2091 197 10.4k
Jean A. Maroun 7313 2591 2023 135 9.4k
Jim Cassidy 9224 3003 2251 122 11.5k
Niall C. Tebbutt 9052 4293 2945 250 12.5k
Fernando Rivera 9997 4628 2525 164 12.6k
Tamas Hickish 9922 4218 3002 142 13.2k
Bruno Landi 5828 2815 1630 68 8.1k

All Works

Loading papers...

Rankless by CCL
2026